Latest KFF Health News Stories
Colorado Says Drug Industry Blocked Its Canada Dreams – And Biden Hasn’t Helped
Colorado’s leaders had grand plans to import cheaper medicines from Canada, after the Trump administration issued rules in 2020 allowing states to try it. But officials in Denver say they’ve been stymied by opposition from drugmakers — as well as the Biden administration’s inaction on the policy. That’s according to a Dec. 1 report we […]
Many Autoimmune Disease Patients Struggle With Diagnosis, Costs, Inattentive Care
Despite the prevalence of autoimmune conditions, like the thyroid disease Hashimoto’s, sometimes finding help can prove frustrating as well as expensive. There are often no definitive diagnostic tests, so patients may rack up big bills as they search for confirmation of their condition and for treatment options.
Health Care Is Front and Center as DeSantis and Newsom Go Mano a Mano
Florida’s Republican Gov. Ron DeSantis and California’s Democratic Gov. Gavin Newsom will square off in a first-of-its-kind debate on Nov. 30. KFF Health News compared the political rivals’ health care positions, showing how their policies have helped — or hindered — the health of their states’ residents.
Evolving Overdose Crisis Shakes Previously Effective Treatments
The prevalence of synthetic drugs is undercutting a previously effective and widely embraced opioid use disorder treatment tactic. Now, the model pioneered in Vermont a decade ago and adopted at sites nationwide, especially in hard-to-reach rural areas, is being forced to evolve.
Journalists Delve Into Open Enrollment, School Nurse Shortages, and More
KFF Health News and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Beyond Insulin: Medi-Cal Expands Patient Access to Diabetes Supplies
California’s Medicaid program is making it easier for people with diabetes to obtain the supplies and equipment they need to manage their blood sugar, partly by relaxing preauthorization requirements that can cause life-threatening delays.
Biden Administration’s Limit on Drug Industry Middlemen Backfires, Pharmacists Say
A rule taking effect Jan. 1 was intended to stop one set of abuses by pharmacy benefit managers, or PBMs, but some pharmacists say it’s enabling these price brokers to simply do new things unfairly.
A New RSV Shot Could Help Protect Babies This Winter — If They Can Get It in Time
Supply problems, a high price tag, and bureaucratic obstacles are slowing the distribution of a therapy that can protect infants from the respiratory syncytial virus. That will leave them unnecessarily at risk of hospitalization this winter, pediatricians fear.
US to Cover HIV Prevention Drugs for Older Americans to Stem Spread of the Virus
The government has proposed that Medicare fully cover preexposure prophylaxis drugs that prevent HIV, a change that could help America catch up with nations in Europe and Africa that are on track to end new infections decades before the U.S. under its current approach.
Prevención del VIH: proponen que Medicare cubra PrEP para adultos mayores
Según el plan de la administración Biden, Medicare cubriría el costo total de los medicamentos de profilaxis previa a la exposición, que previenen la transmisión del VIH.
An Arm and a Leg: John Green vs. Johnson & Johnson (Part 2)
The high price of lifesaving tuberculosis drugs makes them inaccessible to many who need them most. On this episode of “An Arm and a Leg,” hear how a decades-long global fight to reform drug patents is helping to lower the cost.
A New Era of Vaccines Leaves Old Questions About Prices Unanswered
The CDC’s RSV vaccination recommendations beg the question: How much should an immunization that will possibly be given to millions of Americans cost to be truly valuable?
KFF Health News' 'What the Health?': The New Speaker’s (Limited) Record on Health
The House finally has a new speaker: Mike Johnson (R-La). He’s a relative newcomer who’s been a lower-level member of the House GOP leadership. And while he’s an outspoken opponent of abortion and same-sex marriage, his record on other health issues is scant. Meanwhile, the National Institutes of Health appears on track to be getting a new director, and Georgia’s Medicaid work requirement experiment is off to a very slow start. Alice Miranda Ollstein of Politico and Rachel Cohrs of Stat join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Michael Cannon, director of health policy studies at the Cato Institute, a libertarian think tank.
Biden Pick to Lead NIH Finally Has Her Day, but Still Gets Caught Up in Drug Price Debate
Monica Bertagnolli, the president’s choice to head the National Institutes of Health, appeared before a Senate committee this week. Her confirmation has been held up by Sen. Bernie Sanders (I-Vt.), who has demanded President Joe Biden work more aggressively to lower prescription drug prices.
KFF Health News' 'What the Health?': The Open Enrollment Mixing Bowl
Open enrollment for Medicare beneficiaries with private health plans began Oct. 15, to be followed Nov. 1 by open enrollment for Affordable Care Act plans. The selection for both is large — often too large to be navigated easily alone. And people who choose incorrectly can end up with unaffordable medical bills. Meanwhile, those on both sides of the abortion issue are looking to Ohio’s November ballot measure on abortion to see whether anti-abortion forces can break their losing streak in statewide ballot questions since the overturn of Roe v. Wade in 2022.
KFF Health News' 'What the Health?': Health Funding in Question in a Speaker-Less Congress
A bitterly divided Congress managed to keep the federal government running for several more weeks, while House Republicans struggle — again — to choose a leader. Meanwhile, many people removed from state Medicaid rolls are not finding their way to Affordable Care Act insurance, and a major investigation by The Washington Post attributes the decline in U.S. life expectancy to more than covid-19 and opioids. Lauren Weber of The Washington Post, Victoria Knight of Axios, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews physician-author-playwright Samuel Shem about “Our Hospital,” his new novel about the health workforce in the age of covid.
An Arm and a Leg: John Green vs. Johnson & Johnson (Part 1)
Pharmaceutical patents can drive up the costs of lifesaving medications. Hear what author and YouTube star John Green is doing to make tuberculosis drugs more accessible to the people who need them most.
Trump Misplaced Blame When He Said Drug Shortages Were Biden’s Fault
Former President Donald Trump, who’s running for another term in the White House, recently blamed drug shortages on his successor, President Joe Biden. Our findings don’t align with Trump’s claims; by some measures, drug shortages increased more on Trump’s watch than on Biden’s.
Florida Foster Kids Are Given Powerful Medications, but Feds Find State Oversight Lacking
A report by the U.S. Department of Health and Human Services raises troubling questions about the use of powerful medications within Florida’s child welfare system and the risk of overdoses or dangerous side effects if children are given the wrong combination of drugs.
KFF Health News' 'What the Health?': Countdown to Shutdown
Congress appears to be careening toward a government shutdown, as a small band of House conservatives vow to block any funding for the fiscal year that begins Oct. 1 unless they win deeper cuts to health and other domestic programs. Meanwhile, former President Donald Trump continues to roil the GOP presidential primary field, this time with comments about abortion. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Tami Luhby of CNN join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
